[P4–140]: HMG COA REDUCTASE IS A GENETIC MODIFIER FOR RISK, AGE OF ONSET AND ALZHEIMER's DISEASE's CONVERSION WHICH MODULATES PATHOLOGY‐RELATED AD BIOMARKERS

Authors :: Nathalie I.V. Nilsson
Anne Labonté
Doris Dea
Valérie Leduc
Louise Théroux
Judes Poirier
Source :: Alzheimer's & Dementia. 13
Publication Year :: 2017
Publisher :: Wiley, 2017.

Subjects :: medicine.medical_specialty
biology
Epidemiology
business.industry
Health Policy
Disease
Psychiatry and Mental health
Cellular and Molecular Neuroscience
Endocrinology
Developmental Neuroscience
Internal medicine
HMG-CoA reductase
biology.protein
medicine
Neurology (clinical)
Geriatrics and Gerontology
Age of onset
business

Tools